VAX-ID Oncology

You are here

Vaccination can have a major impact on the increasing global cancer burden that is expected to exceed 20 million new cases per year in 2025. Where prophylactic vaccination has the potential to prevent cancer caused by HPV or HBV infection, therapeutic vaccination will boost the body's natural defense of people already diagnosed with potentially any type of cancer. Vax-ID, a unique injection system, can be used for both prophylactic and therapeutic intradermal vaccination.

Oncology brochure